跳至主要内容
临床试验/DRKS00009005
DRKS00009005已完成未知

A three months intake of soy lecithin phosphatidylserine/phosphatidic acid complex (PAS) and effects on the premenstrual syndrome (PMS) - L4-2015

ipogen Ltd.0 个研究点目标入组 48 人开始时间: 2015年8月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • PMS diagnosis;
  • Regular menstrual cycle with a constant cycle duration (25-35 days);
  • Easy access to computer and internet at home

排除标准

  • Known allergies to ingredients of the test substance;
  • Any further psychiatric diseases (e.g. major depressive disorder) as assessed with the Mini-DIPS;
  • Current intake of any drugs besides thyroid medication (TSH values in the normal range, lab results not older than 12 months) and blood pressure medication (stable for 6 months);
  • Intake of nutritional supplements or homeopathic remedies within the two weeks prior to V1;
  • Any current / acute disease besides thyroid
  • Any disease besides minor medical conditions (e.g. seasonal allergies);
  • Females working on nightshifts;
  • Females on a strict diet or practicing extensively sports;
  • Females smoking more than 5 cigarettes/week;
  • Pregnant or lactating;
  • Females planning a pregnancy in the next 12 months;
  • Employee of the sponsor or CRO;
  • Investigator doubts truthfulness of self-reported health information;
  • Females otherwise apparently unsuited (lack of cognitive or verbal skills);
  • Females currently participating in another clinical study

研究者

发起方
ipogen Ltd.

相似试验